AT198352T
Oligonucleotides specific for human papillomavirus
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
59 members in 15 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 47197495 | United States of America | A | |
| 9602429 | European Patent Office (EPO) | W |
Members59
| Document | Office | Kind | |
|---|---|---|---|
| CA2144855A1 | Canada | A1 | |
| WO9406913A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU5162593A | Australia | A | |
| WO9406913A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP0662133A1 | European Patent Office (EPO) | A1 | |
| CA2201588A1 | Canada | A1 | |
| WO9610580A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU3830995A | Australia | A | |
| JPH08504096A | Japan | A | |
| WO9610580A3 | World Intellectual Property Organization (WIPO) | A3 | |
| ZA964447B | South Africa | B | |
| CA2226457A1 | Canada | A1 | |
| WO9639501A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU6300296A | Australia | A | |
| WO9639501A3 | World Intellectual Property Organization (WIPO) | A3 | |
| NO971529D0 | Norway | D0 | |
| NO971529L | Norway | L | |
| EP0784631A1 | European Patent Office (EPO) | A1 | |
| KR970706300A | Republic of Korea | A | |
| CN1168698A | China | A | |
| EP0832214A2 | European Patent Office (EPO) | A2 | |
| AU689447B2 | Australia | B2 | |
| AR002758A1 | Argentina | A1 | |
| JPH11500001A | Japan | A | |
| NZ295056A | New Zealand | A | |
| AU712901B2 | Australia | B2 | |
| EP0832214B1 | European Patent Office (EPO) | B1 | |
| AT198352TThis record | Austria | T | |
| ATE198352T1 | Austria | T1 | |
| DE69611368D1 | Germany | D1 | |
| US6207416B1 | United States of America | B1 | |
| US2001010899A1 | United States of America | A1 | |
| DE69611368T2 | Germany | T2 | |
| US6287759B1 | United States of America | B1 | |
| KR100318516B1 | Republic of Korea | B1 | |
| KR100332602B1 | Republic of Korea | B1 | |
| US2002068820A1 | United States of America | A1 | |
| US6458940B2 | United States of America | B2 | |
| US6509149B2 | United States of America | B2 | |
| KR100359526B1 | Republic of Korea | B1 | |
| US2003055240A1 | United States of America | A1 | |
| US6696242B1 | United States of America | B1 | |
| US6706873B1 | United States of America | B1 | |
| CN1148450C | China | C | |
| US6787145B1 | United States of America | B1 | |
| JP2005013220A | Japan | A | |
| JP2006149393A | Japan | A | |
| JP3889808B2 | Japan | B2 | |
| CA2226457C | Canada | C | |
| CA2144855C | Canada | C | |
| NO326399B1 | Norway | B1 | |
| EP0662133B1 | European Patent Office (EPO) | B1 | |
| AT449178T | Austria | T | |
| ATE449178T1 | Austria | T1 | |
| DE69334299D1 | Germany | D1 | |
| ES2336282T3 | Spain | T3 | |
| EP0784631B1 | European Patent Office (EPO) | B1 | |
| AT518879T | Austria | T | |
| ATE518879T1 | Austria | T1 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Ceased as to paragraph 5 lit. 3 law introducing patent treatiesCeasedRER | RER |
Numbers
- Application
- 96921927
Titles2
- German
- OLIGONUKLEOTIDE SPEZIFISCH FÜR HUMANE PAPILLOMAVIREN
- English
- OLIGONUCLEOTIDES SPECIFIC TO HUMAN PAPILLOMA VIRUSES
Classification
- CPC, 6
- C12N15/1131
- A61K38/00
- A61P31/20
- C12N2310/321
- C12N2310/334
- C12N2310/351
- IPC, 2
- A61K38 00
- C12N15 113